Jonathan Oh

432 total citations
5 papers, 31 citations indexed

About

Jonathan Oh is a scholar working on Oncology, Genetics and Biotechnology. According to data from OpenAlex, Jonathan Oh has authored 5 papers receiving a total of 31 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Genetics and 3 papers in Biotechnology. Recurrent topics in Jonathan Oh's work include Cancer Research and Treatments (3 papers), Virus-based gene therapy research (2 papers) and RNA modifications and cancer (1 paper). Jonathan Oh is often cited by papers focused on Cancer Research and Treatments (3 papers), Virus-based gene therapy research (2 papers) and RNA modifications and cancer (1 paper). Jonathan Oh collaborates with scholars based in United States. Jonathan Oh's co-authors include Luisa Manning, Gladice Wallraven, Minal Barve, Ernest Bognar, Phylicia Aaron, Rodney P. Rocconi, Neil Senzer, John Nemunaitis, Laura Stanbery and Staci Horvath and has published in prestigious journals such as Journal of Clinical Oncology and Gynecologic Oncology Reports.

In The Last Decade

Jonathan Oh

5 papers receiving 31 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Oh United States	4	26	15	11	10	4	5	31
Carlos Hernández Hernández United States	2	20 0.8×	7 0.5×	5 0.5×	14 1.4×	5 1.3×	3	26
Jaryse Harris United States	3	29 1.1×	29 1.9×	14 1.3×	3 0.3×	3 0.8×	6	55
Tomohiro Iida Japan	4	26 1.0×	27 1.8×	4 0.4×	6 0.6×	2 0.5×	7	50
Hannah Beer United States	2	15 0.6×	6 0.4×	4 0.4×	5 0.5×	5 1.3×	4	22
Zhuqing Xiong China	2	26 1.0×	18 1.2×	18 1.6×	2 0.2×	8 2.0×	2	51
Jennifer Ploski United Kingdom	2	9 0.3×	7 0.5×	5 0.5×	14 1.4×	5 1.3×	5	27
Rumyana Ilieva United Kingdom	4	23 0.9×	3 0.2×	11 1.0×	13 1.3×	8 2.0×	5	28
R. Dunn United States	3	23 0.9×	4 0.3×	10 0.9×	18 1.8×	2 0.5×	5	32
Y. Unno South Korea	3	17 0.7×	20 1.3×	33 3.0×	4 0.4×		7	49
Michelle Wantoch United Kingdom	2	12 0.5×	6 0.4×	4 0.4×	2 0.2×	4 1.0×	2	23

Countries citing papers authored by Jonathan Oh

Since Specialization

Citations

This map shows the geographic impact of Jonathan Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Oh more than expected).

Fields of papers citing papers by Jonathan Oh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Oh. The network helps show where Jonathan Oh may publish in the future.

Co-authorship network of co-authors of Jonathan Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Oh. A scholar is included among the top collaborators of Jonathan Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Oh. Jonathan Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Rocconi, Rodney P., Elizabeth A. Grosen, Sharad Ghamande, et al.. (2020). Randomized double-blind placebo-controlled trial of primary maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: Efficacy assessment in BRCA1/2-wt patients.. Journal of Clinical Oncology. 38(15_suppl). 6017–6017. 3 indexed citations

2.

Oh, Jonathan, Minal Barve, Neil Senzer, et al.. (2020). Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance. Gynecologic Oncology Reports. 34. 100648–100648. 19 indexed citations

3.

Manning, Luisa, Minal Barve, Gladice Wallraven, et al.. (2017). Assessment of Low Dose Vigil® Engineered Autologous Tumor Cell (EATC) Immunotherapy in Patients with Advanced Solid Tumors. 2(1). 3 indexed citations

4.

Oh, Jonathan, Minal Barve, Devansu Tewari, et al.. (2017). Clinical trial in progress: A phase 3 study of maintenance bi-shRNA-furin/GM-CSF-expressing autologous tumor cell vaccine in women with stage IIIb-IV high-grade epithelial ovarian cancer.. Journal of Clinical Oncology. 35(15_suppl). TPS5604–TPS5604. 4 indexed citations

5.

Nemunaitis, John, Neil Senzer, Minal Barve, et al.. (2014). Survival effect of bi-shRNA^furin/GMCSF DNA-based immunotherapy (FANG) in 123 advanced cancer patients to α-interferon-ELISPTOT response.. Journal of Clinical Oncology. 32(15_suppl). 3077–3077. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact